ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation

Bong Seok Kang1, Yoon Jin Hwang1,2, Zigang Dong3

  • 1Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu, 41944, Republic of Korea.

Insights

ERK1 directly inhibits JNK1 activity, suppressing Ras/JNK-mediated cell transformation. This antagonistic interaction between ERK1 and JNK1 offers a novel mechanism in cancer signaling.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • ERK1 and ERK2 are highly homologous, making functional differentiation difficult.
  • Mitogen-activated protein (MAP) kinase pathways are often depicted as linear but exhibit crosstalk.
  • The precise nature and impact of MAP kinase crosstalk remain unclear.

Purpose of the Study:

  • To investigate direct interactions and functional differences between ERK1 and JNK1.
  • To elucidate the role of ERK1 in repressing Ras/JNK-mediated cell transformation.
  • To explore the in vivo relevance of ERK1/JNK1 interactions in tumorigenesis.

Main Methods:

  • Investigated direct physical interactions between ERK1 and JNK1.
  • Assessed the impact of ERK1 on JNK1 phosphorylation and activity.
  • Analyzed ERK1 and JNK/c-Jun activation in normal and liver cancer tissues.

Main Results:

  • ERK1, but not ERK2, directly interacts with and antagonizes JNK1 phosphorylation and activity.
  • ERK1-JNK1 antagonism suppresses neoplastic cell transformation via the Ras/JNK/c-Jun pathway.
  • ERK1 phosphorylation is decreased, while JNK/c-Jun activation is increased in liver cancer tissues compared to normal tissues.

Conclusions:

  • Established a novel mechanism of trans-regulation between ERK1 and JNK1 signaling modules.
  • Demonstrated an antagonistic ERK1/JNK1 interaction crucial for suppressing Ras/JNK-mediated transformation.
  • Provided in vivo evidence linking ERK and JNK pathway dysregulation to liver tumorigenesis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K